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Background: Community studies reveal people with coronary heart disease (CHD) are twice as likely to be
depressed as the general population and that this co-morbidity negatively affects the course and outcome of both
conditions. There is evidence for the efficacy of collaborative care and case management for depression treatment,
and whilst NICE guidelines recommend these approaches only where depression has not responded to
psychological, pharmacological, or combined treatments, these care approaches may be particularly relevant to the
needs of people with CHD and depression in the earlier stages of stepped care in primary care settings.
Methods: This pilot randomised controlled trial will evaluate whether a simple intervention involving a
personalised care plan, elements of case management and regular telephone review is a feasible and acceptable
intervention that leads to better mental and physical health outcomes for these patients. The comparator group
will be usual general practitioner (GP) care.
81 participants have been recruited from CHD registers of 15 South London general practices. Eligible participants
have probable major depression identified by a score of ≥8 on the Hospital Anxiety and Depression Scale
depression subscale (HADS-D) together with symptomatic CHD identified using the Modified Rose Angina
Questionnaire.
Consenting participants are randomly allocated to usual care or the personalised care intervention which involves a
comprehensive assessment of each participant’s physical and mental health needs which are documented in a care
plan, followed by regular telephone reviews by the case manager over a 6-month period. At each review, the
intervention participant’s mood, function and identified problems are reviewed and the case manager uses
evidence based behaviour change techniques to facilitate achievement of goals specified by the patient with the
aim of increasing the patient’s self efficacy to solve their problems.
Depressive symptoms measured by HADS score will be collected at baseline and 1, 6- and 12 months post
randomisation. Other outcomes include CHD symptoms, quality of life, wellbeing and health service utilisation.* Correspondence: a.tylee@iop.kcl.ac.uk
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the health and social care needs of people with depression and CHD in primary care.
Trial registration: ISRCTN21615909.Background
Coronary heart disease (CHD) is a common chronic dis-
ease, affecting around 3.5% of the UK population [1]; it
is the most common cause of mortality in the world [2]
and in the UK accounted for 18% of premature deaths in
men and 9% in women in 2008 [3]. It was ranked as the
second leading cause of disability in high- and middle-
income countries in 2004 [2].
Depression is likewise an important public health prob-
lem: it has a 12-month prevalence of around 4% [4] and is
currently the leading cause of global disease burden in
high- and middle-income countries [2]. For at least half of
all people who experience an episode, depression is char-
acterised by relapses, and for 10 - 20% it involves chronic
symptoms [5,6]. Depression co-occurs in a substantial
proportion of patients with chronic medical conditions in-
cluding CHD; and this co-occurrence is associated with
poorer quality of life and increased morbidity and mortal-
ity [7,8]. There is consistent evidence that depression is
predictive of subsequent coronary events in people with
established CHD and the risk of fatal cardiac events in this
population is more than doubled when this is co-morbid
with depression [7]. Mortality risk appears most strongly
associated with depression onset following the acute cor-
onary syndrome [9].
The association between depression and CHD appears
to be related to physiological mechanisms such as
altered inflammatory responses and changes in platelet
aggregation [10], as well as to a range of health beha-
viours. Factors such as sedentary lifestyle, unhealthy diet,
cigarette smoking and reduced adherence to exercise or
medication regimens elevate the risk of adverse health
outcomes [11]. Providing interventions that facilitate
changes in health behaviour as well as impacting on de-
pression has clear relevance for this patient group.
In the UK, most people with depression are treated in
primary care [12], however there is limited provision
within current services for its longer-term management,
or for care that addresses its frequent co-morbidity with
medical conditions. Improving the management of de-
pression in people with CHD is an important goal, with
the potential for benefit for both psychological and phys-
ical health outcomes. Researchers have investigated the
effectiveness of pharmacological and psychological ther-
apies with patients experiencing this combination of
conditions, and systematic reviews conducted for the re-
cent National Institute for Health and Clinical Excel-
lence clinical guideline clearly show that these treatment
approaches are effective on depression outcomes incomparison with standard care [11]. There is also emer-
ging evidence for the benefit of these types of interven-
tion on a range of physical health outcomes including
glycaemic control [13], low-density lipoprotein choles-
terol, and systolic blood pressure [14].
There is particular value in a coordinated treatment
approach that addresses the physical and psychological
needs of this patient group within primary care, and
avoids the fragmentation of care delivery that can ham-
per the management of long-term conditions [15]. The
links between depression and CHD are likely to be
complex, but lifestyle factors appear especially import-
ant for cardiac outcomes as well as for quality of life
[16]. It appears that certain interventions used in
chronic disease management are of particular relevance.
Components such as education about the condition,
interventions to encourage physical exercise, systematic
monitoring of the patient’s response and concordance
to treatment, and assisting lifestyle modification have
been found to be associated with psychological im-
provement as well as benefiting physical health. A re-
cent systematic review has identified benefit for
depression outcomes from such community-based heart
disease interventions [17].
The current study evaluates a novel personalised care
approach using regular pro-active contact and follow-up
and involving elements of case management. The term
‘case management’ was first used in the 1950s in the
USA to describe the extended community services
needed for discharged mental health patients, and has
subsequently developed to become a widely-used ap-
proach for managing the care required by people with
complex health and social care needs [18]. It is a system-
atic proactive approach used to assess and organize care
using a health professional (typically a nurse or social
worker), the case manager, to work collaboratively with
the patient to plan and monitor treatments and sup-
ports. Key elements of this role involve using scheduled
follow-ups to help develop self-management techniques;
providing education about the illnesses; supporting on-
going treatments whilst addressing non-adherence or
lack of improvement by adjustments or facilitating
changes; and where appropriate coordinating care across
the health and social care system [19]. In England, NHS
case management has been a central aspect of the long-
term conditions strategy, and is focussed explicitly on
the care of those people with complex long-term needs
who are at high risk of decline and unplanned reactive
specialist care such as hospital admissions [20].
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proach is more broadly focused than case management
which typically exclusively targets the most complex and
vulnerable patients; and is delivered by means of regular
telephone contacts. It is centred on collaborative work-
ing underpinned by a care plan agreed between the pa-
tient and case manager and incorporates appropriate
and accessible health education and the support for self-
care, using evidence based behaviour change techniques
that are noted in UK health policy as the main approach
to care for the majority of people with long-term condi-
tions. The intention within this study is to evaluate an
intervention that could be feasibly delivered by health
professionals in primary care such as practice nurses
who are in an excellent position to provide such an ap-
proach to patients in the management of chronic pro-
blems [21]. Discussion of cases between the case
manager and an academic GP will be used each week to
mirror the type of case review that is available within the
primary care team.
The intervention is designed to enhance current prac-
tice with only minimal additional administration and
training. It was developed on the basis of reviews of the
relevant literature [22] and qualitative studies of patients’
and health professionals’ views on treatment needs for
CHD and comorbid depression. This study forms part of
a broader programme of research including a prospective
cohort study of 803 primary care patients with coronary
heart disease to explore the relationship with depression
and a nested case–control study to investigate genetic
and blood-biomarkers as predictors of depression [23].
Aims
This study seeks to examine the feasibility and accept-
ability of telephone-delivered personalised care com-
pared with treatment as usual (TAU) for a subset of
primary care CHD patients who have probable concur-
rent depression, and to explore the types of needs and
problems identified by patients in collaboration with
their case manager. The methods of the trial will also be
tested to inform a definitive trial. The primary outcome
to be tested will be the severity of depression features
measured by the Hospital Anxiety and Depression Scale
[24] depression sub-scale (HADS-D) at 1-, 6-, and 12-
months following randomisation. Secondary outcomes
tested will include measures of CHD symptoms, well-
being, and health service utilisation.
Methods/design
This study is a randomised controlled trial with random-
isation by individual patients within practices recruited
by the Primary Care Research Network-Greater London.
The comparison is between usual primary care (control
arm), and personalised care involving regular telephonefollow-up by nursing health professionals in addition to
usual primary care (intervention arm).
Sample size
Although estimation of a definitive effect size is not the
focus of this pilot study, a sample size calculation indi-
cated that to show a mean difference between interven-
tion and control of ≥ 3 on the HADS Depression
subscale, assuming a pooled standard deviation around
mean scores of 4, 30 participants per group are needed
for 90% power at the 5% significance level. This is also
in line with the minimum of 12 per group suggested for
pilot studies [25]. To allow for loss to follow-up esti-
mated at 25%, our plan was to recruit 80 participants
(40 per arm) into the RCT.
Recruitment - practices
Practices in South London were eligible for inclusion if
they kept a register of patients with CHD for the Quality
and Outcomes Framework (QOF) and were willing to be
involved in liaison concerning patients in the interven-
tion arm where necessary. Practices already involved in
the UPBEAT-UK cohort study were excluded. Recruit-
ment commenced in October 2010. 15 general practices
were approached by the Greater London Primary Care
Research Network (PCRN-GL), one of eight local pri-
mary care research networks for England funded by the
National Institute for Health Research Clinical Research
Network (NIHR CRN) which assist in coordinating and
supporting NHS primary care research, and all practices
agreed to participate.
Recruitment - participants
All patients on practice case registers for CHD were sent
study information and consent to contact requests by
participating general practitioners. Those patients who
provided consent were contacted by study researchers
and assessed for depression using the HADS-D and for
symptoms relating to CHD using the Modified Rose An-
gina Questionnaire [26]. Patients with symptomatic
CHD (i.e. current chest pain) and a score of ≥8 on the
HADS-D scale [24]were eligible to participate in the
study. Those providing fully informed consent to partici-
pate were then randomly allocated to either to the inter-
vention (personalised care) or the treatment as usual
(TAU) arm of the study (Figure 1).Inclusion Criteria (Participants)
 Symptomatic CHD as scored on the modified Rose
Angina Questionnaire [26]
 A score ≥8 on the depression part of the Hospital
Anxiety and Depression Scale [24]
 Aged 18 years or over
General Practices recruited by PCRN-GL that -  
• maintain a register of patients with CHD, 
• are willing to be involved in patient case management as necessary. 
Practices identify patients from CHD registers and send 
study information and a ‘consent to contact’ (by research 
team) reply forms. 
Patients consenting to researcher contact are screened 
using the HADS-D and Rose Angina Questionnaire.  
Patients who score  8 on HADs-D and have self-reported 
symptomatic CHD randomly allocated by independent agency.  
Usual primary care 
Follow-up measures at 1-, 6-, and 12-months 
Tailored care in addition 
to usual care  
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 Temporary registrations
 Actively suicidal patients
 Psychotic depression as evidenced by delusions and/
or hallucinations
 Non-English speaking
 Participants currently in hospital for treatment of
their CHD
Figure 1 Flow chart of the UPBEAT-UK trial.Randomisation
Randomisation was conducted independently by the Men-
tal Health and Neurosciences Clinical Trials Unit (CTU)
at King's College London and allocation concealment was
ensured by the CTU independent database programme.
Randomisation was at patient level. A random permuted
block design was used to approximately balance the num-
bers in the control and intervention groups.Intervention
The intervention was developed following a literature re-
view and qualitative studies that explored the views of
patients and service providers concerning health needs
and care delivery suitable for coronary heart disease and
co-morbid depression. Patients’ perspectives on treat-
ments were examined by semi-structured interview with30 participants of the UPBEAT-UK cohort study with
probable depression (identified by PHQ-9 score) in
addition to CHD, and by two focus groups involving par-
ticipants with symptomatic CHD (identified by Rose An-
gina Questionnaire) and probable depression (by PHQ-9
score). Interviews were conducted with 12 practice
nurses and 10 GPs working in practices in 4 ethnically
and culturally diverse parts of South London. These
studies indicated that an individualised case
management-based intervention of a type that could be
delivered by practice nurses was likely to be acceptable
and effective.
On the basis of these investigations, we developed a
tailored face-to-face assessment and telephone-delivered
follow-up provided by clinically qualified case managers.
Because this was an exploratory study, the case managers
were members of the research team, and rather than
practice nurses they were a community psychiatric nurse
and a health psychologist who is also a registered nurse.
Neither of the case managers is involved in collecting the
follow-up data.
The case managers arrange to meet with each partici-
pant randomised to the intervention arm for an initial
assessment. Central to the care model is developing a
shared plan of care, and in this study the initial assess-
ment meeting between the patient and case manager is
Table 1 Measures used at each time point in the
UPBEAT-UK randomised controlled trial
Outcome Parameter Instruments
Primary Outcome
Depression HADS-depression subscale [24]
Secondary Outcomes
Depression PHQ-9 [29]
Coronary Heart Disease Modified Rose Angina Questionnaire [26],
Specific Activity Schedule [30],
Guy’s Hospital Chest Pain
Questionnaire [31]
Quality of Life Euroqol 5day [32], Medical Outcomes
Survey Short Form-12 (SF-12) [33]
Adherence to medication Adapted version of Morisky
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based on a comprehensive assessment (see Additional
file 1). The format of the assessment materials has been
specifically based on the outcome areas identified in
the Department of Health green paper Independence,
Well-being and Choice [27], enabling a multi-factorial
assessment of each patient’s physical, mental and social
wellbeing and relevant environmental factors. This
assessment follows UK developments towards a com-
mon assessment framework for adults [28]. A copy of
the PCP is kept by the participant, a copy by the case
manager and a copy is sent to the participant’s GP. The
case manager helps the participant choose up to two
main problems on which to work. The focus will be on
helping the patients to identify problems they think are
contributing to their depression, rather than the case
manager imposing their views. The case manager will
provide health advice, but a key aim is to develop the
patient’s confidence in identifying and solving their own
problems. The case managers will be familiar with a
range of evidence based behaviour change interventions
such as goal setting and rating importance and confi-
dence to change (importance/confidence ruler), which
they will use to enhance the patient’s self- efficacy in self
management. The case managers also provide written
information where necessary about depression, CHD
and other health problems, and about appropriate local
resources for participants to access, as well as liaising
with other health professionals involved in the partici-
pant’s care as appropriate.
The initial assessment will last up to an hour, and
patients will be followed up by the case manager by tele-
phone (or email, if the patient prefers) for 6 months.
Contacts are planned to be at weekly or two-weekly
intervals, although the frequency will be reviewed in re-
lation to the patient’s needs and actual intervals will be
recorded. During the follow-up, the participant’s PCP
will be reviewed with particular emphasis on mutually
prioritised problems and new goals will be set in collab-
oration with the participant as appropriate; each tele-
phone follow-up session is planned to last between 10
and 30 min, but actual durations will be recorded.adherence questionnaire [34]
Life events List of Threatening Events
Questionnaire [35]
Social problems Social Problems Questionnaire [36]
Health Service Utilisation Client Service Receipt Inventory
(CSRI) [37]
Illness Perceptions Brief Illness Perceptions
Questionnaire [38]Comparator
Participants randomised to the control group will receive
treatment as usual by their GP and any other relevant
professionals including the full range of physical and






Participants will be followed up at 1-, 6- and 12-months
post randomisation.The primary outcome measure is depression status
and severity identified by the depression subscale items
of the Hospital Anxiety and Depression Scale (HADS)
[24]. This rating scale is comprised of seven items and
has been widely used to examine depression in commu-
nity populations and particularly among people with co-
existing medical conditions.
Additionally a number of secondary outcome mea-
sures will be used to examine the efficacy of this
intervention and the appropriateness and acceptability
of measurement instruments (Table 1). These will in-
clude measures of CHD symptoms, well-being and
quality of life, and use of health services. These vari-
ables will all be measured at baseline, and the three
follow-up time-points.Blinding
In a randomised comparison of this type, patient blinding
is clearly impossible. The researchers will however be
blind to randomisation status, and will be asked to give
their opinion on randomisation status to determine
whether blinding is adequate. If researcher unblinding
occurs, a pair of patients (including the patient whose al-
location status may have been identified) will be switched
to another researcher within the team.
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Descriptive analyses will be used to provide summary
estimates of outcome measures, focussing on the drop-
out rate at each time point. A linear mixed effect model
for longitudinal data will be used to estimate (using
maximum likelihood) between treatment arms the differ-
ence in HADS-D scores at 1, 6 and 12 months overall
(taking account of any time trends). Intention to treat
analysis will be used. While the sample size will not be
sufficient to test clustering effects formally, sources of
clustering (such as the patient’s GP practice) andContact established n=163
Un-contactable n=7
Randomised n=81
Usual care n=41 Intervention n
Consent to be contacted n=1001
Ineligible n=831
(HADS-D <8; no concurrent cardiac pain)
Eligible for assessment n=170
Total responses n=1100
Sampling Frame
People on coronary heat disease registers of 17 partici
practices (total practice population 150,973)
Total population on CHD register n=3325
Invited by post to participate n=3305
Received baseline visit n=126
Figure 2 Consort diagram: recruitment and treatment group allocatioapproximate size of inter-cluster correlation coefficient
will be identified so that they can be taken into account
in any future definitive trial.Results of recruitment
Recruitment ceased in May 2011. The recruitment target
was achieved, with 81 eligible patients from 15 practices
consenting to participation. Figure 2 details recruitment
at each stage, reasons for exclusion and numbers
randomised.Ineligible at baseline n=45
HADS-D <8 n= 40
Schizophrenia/hallucinations n=2
No chest pain n=2
English too poor n=1
=40
Excluded at point of phone contact
Refused n=29
Ineligible: language difficulties n=6
or DNAx3 n=2
Declined participation n= 99
Declined n=81
Deceased (reported by relative 
or Practice Manager) n= 3
Unable (health/langua ge reasons) n=10
Feels study is not applicable n=5
pating general 
Excluded by GP 
n=20
n.
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This trial received ethical approval from the South East
London Research Ethics Committee (REC Ref No. 10/
H0808/51).
Discussion
This pilot RCT recruited 81 participants within the
South London area over an 8-month period. The recruit-
ment method using structured searches of general prac-
tice QOF databases for potential participants who were
then approached by means of a letter sent by the practice
resulted in the planned number of patients being
recruited. This method of recruitment therefore appears
to be feasible and effective. The ease of recruitment of
both practices and patients suggests that the intervention
is perceived as acceptable and potentially useful by both
clinicians and depressed people with CHD (Fig. 2).
The intervention has been designed on the basis of a
qualitative examination of patient and provider views
and reviews of approaches to managing depression and
long-term conditions in primary care. It aims to address
health and social care needs in a practical, achievable
and patient-focused way. The numbers recruited should
allow us to examine the feasibility and acceptability of
this approach to care, to ascertain the size of effects
associated with this intervention and to determine the
optimum design of a definitive trial. Direct contact with
patients not opting in may have improved recruitment
even further as it is possible that depressed patients may
have not replied even if they had been potentially inter-
ested in the intervention.
Additional file 1
Additional file 1: UPBEAT-UK: Personalised Health Plan for Heart
and Mind).
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